Multikinase inhibitors

MYLAN SM 50 MYLAN SM 50 Pill - yellow capsule-shape, 22mm

Pill with imprint MYLAN SM 50 MYLAN SM 50 is Yellow, Capsule-shape and has been identified as Sunitinib Malate 50 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunitinib (Sunitinib [ soo-nit-in-ib ])-MYLAN SM 50 MYLAN SM 50-50 mg-Yellow-Capsule-shape

Sunitinib
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: MYLAN SM 50 MYLAN SM 50
Strength: 50 mg
Color: Yellow
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-6680
Inactive Ingredients: Silicon dioxide, Croscarmellose sodium, Gelatin, Magnesium stearate, Mannitol, Sodium lauryl sulfate, Titanium dioxide, Ferric oxide yellow, Ammonia, Ferrosoferric oxide, Propylene glycol, Shellac,
Latest News
Related Drugs